Rise Therapeutics, LLC SBIR Phase I Award, July 2022
A SBIR Phase I contract was awarded to Rise Therapeutics, LLC in July, 2022 for $282,514.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
282,514
0
Government Branch
Date Awarded
July 15, 2022
0
End Date
July 14, 2023
0
SBIR/STTR Award Recipient
Contract Number (US Government)
1R43TR004300-01
0
Award Phase
Phase I
0
Award Type
SBIR
0
Official Website
Find more entities like Rise Therapeutics, LLC SBIR Phase I Award, July 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.